Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone

被引:1
|
作者
Ulivieri, F. M. [1 ]
Piodi, L. P. [2 ]
Marotta, G. [1 ]
Marchelli, D. [1 ]
Corradini, C. [3 ]
Parravicini, L. [3 ]
Verdoia, C. [3 ]
Gerundini, P. [1 ]
机构
[1] Osped Maggiore Fdn IRCCS Padiglione Granelli, Dept Nucl Med, Via F Sforza 35, Milan, Italy
[2] Osped Maggiore Fdn IRCCS, Dept Gastroenterol, Milan, Italy
[3] Univ Milan, G Pini Hosp, Dept Orthopaed & Traumatol, Milan, Italy
关键词
Bone metabolism; Neridronate; Osteoprotegerin; Paget's disease of bone;
D O I
10.1007/s10195-006-0147-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients (4 men) affected by active Paget's disease of bone (6 polyostotic, 3 monostotic) not responsive to clodronate were studied. Serum OPG, osteocalcin, total and bone isoenzyme of alkaline phosphatase (AP and BAP, respectively), and urinary deoxypyridinoline (DPD) were measured before and 5 months after neridronate treatment (100 mg/day, i.v. for two days). A scintigraphic activity index (SAI) was also calculated before treatment. Mean baseline OPG levels were within normal values and were not significantly different 5 months after neridronate treatment. In contrast, there were significant reductions in AP (41.9%, p<0.02) and BAP (38.8%, p<0.04). Serum OPG levels correlated with DPD (r=0.925) and SAI (r=0.689). Although OPG is an important regulator of bone metabolism, in our series of already treated patients it was not a sensitive marker for diagnosing Paget's disease and for monitoring the response to pharmacological treatment, whereas AP and BAP confirmed their clinical usefulness. This preliminary study requires confirmation by a study with a larger population.
引用
收藏
页码:192 / 194
页数:3
相关论文
共 50 条
  • [41] Current options for the treatment of Paget's disease of the bone
    Merlotti, Daniela
    Gennari, Luigi
    Martini, Giuseppe
    Nuti, Ranuccio
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2009, 1 : 107 - 120
  • [42] Zoledronic acid for treatment of Paget"s disease of bone
    Devogelaer, Jean-Pierre
    Manicourt, Daniel H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (16) : 2863 - 2869
  • [43] Successful treatment of dysphagia in Paget's disease of the bone
    Varadarajulu, S
    Reddy, S
    Noone, T
    Payne, KM
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (09) : 2112 - 2115
  • [44] Osteoprotegerin deficiency (Juvenile Paget's disease): Responses to oral and IV bisphosphonates in 3 children
    Wenkert, D.
    Natter, M.
    Otsuka, M.
    Fish, N.
    Lopez-Benitez, J.
    Markowitz, M.
    McAlister, W.
    Mumm, S.
    Whyte, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S404 - S404
  • [45] Usefulness of Mapping Biopsy in the Treatment of Penoscrotal Extramammary Paget’s Disease
    Curtis A. Pettaway
    Annals of Surgical Oncology, 2017, 24 : 3115 - 3115
  • [46] Usefulness of Mapping Biopsy in the Treatment of Penoscrotal Extramammary Paget's Disease
    Park, Seong Oh
    Ha, Jeong Hyun
    Hong, Ki Yong
    Chang, Hak
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) : 3229 - 3236
  • [47] Usefulness of Mapping Biopsy in the Treatment of Penoscrotal Extramammary Paget’s Disease
    Seong Oh Park
    Jeong Hyun Ha
    Ki Yong Hong
    Hak Chang
    Annals of Surgical Oncology, 2017, 24 : 3229 - 3236
  • [48] TREATMENT OF PAGET DISEASE OF BONE
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1948, 1 (4562): : 1165 - 1166
  • [49] CLINICAL FEATURES, DIAGNOSTIC EVALUATION AND RESPONSES TO TREATMENT IN PAGET'S DISEASE OF BONE IN A CENTER SPECIALIZED IN BONE METABOLISM
    Sarli, Marcelo
    Collaceli, Maria D.
    Jerkovich, Fernando
    Rey, Paula
    Spivacow, Rodolfo
    Zanchetta, Maria B.
    MEDICINA-BUENOS AIRES, 2022, 82 (03) : 408 - 414
  • [50] Paget's disease of bone
    Rousière, M
    Michou, L
    Cornélis, F
    Orcel, P
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (06): : 1019 - 1041